Editas Medicine Inc
EDIT
Market Cap$538.34M
Close$
$9.73
66.3% upside
Current Fair Value
66.3% upsideUndervalued by 66.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $538.34 Million |
|---|---|
| Enterprise Value | $215.22 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.02 |
| Beta | 1.28 |
| Outstanding Shares | 81,813,850 |
| Avg 30 Day Volume | 1,995,544 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.51 |
|---|---|
| PEG | 5.1 |
| Price to Sales | - |
| Price to Book Ratio | 1.46 |
| Enterprise Value to Revenue | 2.75 |
| Enterprise Value to EBIT | -1.27 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Editas Medicine Inc
CEO: Cynthia Collins